2022-07-02 | NDAQ:YQ | Press Launch

2022-07-02 | NDAQ:YQ | Press Launch

Bragar Eagel & Squire, P.C., a nationally acknowledged stockholder rights legislation agency, is investigating potential

Bragar Eagel & Squire, P.C., a nationally acknowledged stockholder rights legislation agency, is investigating potential claims towards 17 Training & Know-how Group, Inc. (“17 E&T” or the “Firm”) (NASDAQ: YQ) on behalf of 17 E&T stockholders. Our investigation issues whether or not 17 E&T has violated the federal securities legal guidelines and/or engaged in different illegal enterprise practices.

Click on right here to take part within the motion.

On or round December 4, 2020, 17 E&T carried out its preliminary public providing, promoting 27.4 million American Depositary Shares (“ADSs”) priced at $10.50 per ADS.

Then, on June 10, 2022, 17 E&T introduced its first quarter monetary outcomes, reporting a internet lack of $3.9 million alongside an almost 50% fall in income from the prior 12 months to $36.82 million.

On this information, 17 E&T’s inventory value fell $1.65 per share, or 21.31%, to shut at $2.40 per share on June 10, 2022.

Should you bought or in any other case acquired 17 E&T shares and suffered a loss, are a long-term stockholder, have info, wish to study extra about these claims, or have any questions regarding this announcement or your rights or pursuits with respect to those issues, please contact Brandon Walker or Melissa Fortunato by e mail at [email protected], by phone at (212) 355-4648, or by filling out this contact kind. There isn’t a value or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally acknowledged legislation agency with workplaces in New York and California. The agency represents particular person and institutional traders in business, securities, spinoff, and different complicated litigation in state and federal courts throughout the nation. For extra details about the agency, please go to www.bespc.com. Lawyer promoting. Prior outcomes don’t assure comparable outcomes.

Leave a Reply

Your email address will not be published. Required fields are marked *